Article Information
vol. 9 no. 420
- Received for publication November 15, 2016
- Resubmitted July 28, 2017
- Accepted for publication October 30, 2017
- .
Author Information
- David Lagares1,*,
- Alba Santos1,†,
- Paula E. Grasberger1,†,
- Fei Liu2,
- Clemens K. Probst1,
- Rod A. Rahimi1,
- Norihiko Sakai1,3,
- Tobias Kuehl1,
- Jeremy Ryan4,
- Patrick Bhola4,
- Joan Montero4,
- Mohit Kapoor5,
- Murray Baron6,
- Xaralabos Varelas7,
- Daniel J. Tschumperlin2,8,
- Anthony Letai4 and
- Andrew M. Tager1,‡
- 1Fibrosis Research Center and Center for Immunology and Inflammatory Diseases, Division of Pulmonary and Critical Care Medicine, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
- 2Molecular and Integrative Physiological Sciences Program, Harvard T. H. Chan School of Public Health, Boston, MA 02115, USA.
- 3Division of Nephrology and Division of Blood Purification, Kanazawa University Hospital, Kanazawa, Japan.
- 4Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.
- 5Krembil Research Institute, University Health Network and Department of Surgery and Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
- 6Jewish General Hospital, McGill University, Montreal, Quebec, Canada.
- 7Department of Biochemistry, Boston University School of Medicine, Boston, MA 02118, USA.
- 8Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN 55905, USA.
- ↵*Corresponding author. Email: dlagares{at}mgh.harvard.edu